← Back to Screener
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY)
Price$47.99
Favorite Metrics
Price vs S&P 500 (26W)-11.02%
Price vs S&P 500 (4W)-4.04%
Market Capitalization$116.32B
P/E Ratio (Annual)12.64x
Indicated Dividend Yield (Annual)5.02%
All Metrics
P/CF (Annual)9.05x
Book Value / Share (Quarterly)$69.55
P/TBV (Annual)26.35x
Indicated Dividend (Annual)$4.62
Revenue Growth (3Y)0.97%
Cash Flow / Share (Quarterly)$5.81
Payout Ratio (TTM)122.16%
Price vs S&P 500 (YTD)-4.07%
Gross Margin (TTM)72.55%
Net Profit Margin (TTM)17.71%
EPS (TTM)$11.99
10-Day Avg Trading Volume2.36M
EPS Excl Extra (TTM)$11.99
Revenue Growth (5Y)4.57%
EPS (Annual)$7.54
Dividend / Share (Annual)$4.46
ROI (Annual)8.52%
Gross Margin (Annual)72.07%
Net Profit Margin (5Y Avg)15.32%
Cash / Share (Quarterly)$7.46
P/E Basic Excl Extra (TTM)7.91x
Revenue Growth QoQ (YoY)16.46%
EPS Growth (5Y)-8.08%
P/E Normalized (Annual)12.64x
ROA (Last FY)6.16%
Revenue Growth TTM (YoY)69.14%
EBITD / Share (TTM)$14.52
ROE (5Y Avg)9.13%
Operating Margin (TTM)17.38%
Cash Flow / Share (Annual)$10.64
P/B Ratio1.38x
P/B Ratio (Quarterly)1.41x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.58x
Net Interest Coverage (TTM)23.62x
ROA (TTM)9.73%
EPS Growth QoQ (YoY)-37.49%
EV / EBITDA (TTM)7.38x
EPS Incl Extra (Annual)$7.54
Current Ratio (Annual)1.09x
Quick Ratio (Quarterly)1.09x
3-Month Avg Trading Volume2.35M
52-Week Price Return-12.13%
EV / Free Cash Flow (Annual)10.21x
P/E Incl Extra (TTM)7.91x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$3.72
P/S Ratio (Annual)2.11x
Asset Turnover (Annual)0.37x
52-Week High$98.36
Operating Margin (5Y Avg)18.18%
EPS Excl Extra (Annual)$7.54
Tangible BV CAGR (5Y)-38.89%
26-Week Price Return-2.28%
Quick Ratio (Annual)1.09x
13-Week Price Return1.55%
Total Debt / Equity (Annual)0.28x
Current Ratio (Quarterly)1.09x
Enterprise Value$131,241.677
Revenue / Share Growth (5Y)5.24%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)3.19%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.38x
Pretax Margin (Annual)13.22%
Cash / Share (Annual)$7.46
3-Month Return Std Dev21.85%
Gross Margin (5Y Avg)70.09%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-0.21%
EBITDA Interim CAGR (5Y)-4.33%
ROE (Last FY)10.95%
Net Interest Coverage (Annual)19.89x
EPS Basic Excl Extra (Annual)$7.54
P/FCF (TTM)7.96x
Receivables Turnover (TTM)6.59x
EV / Free Cash Flow (TTM)18.70x
Total Debt / Equity (Quarterly)0.28x
EPS Incl Extra (TTM)$11.99
Receivables Turnover (Annual)5.50x
ROI (TTM)13.35%
Dividend Growth Rate (5Y)4.30%
P/S Ratio (TTM)1.40x
Pretax Margin (5Y Avg)17.25%
Revenue / Share (Annual)$45.09
Tangible BV / Share (Annual)$3.72
Forward P/E9.68x
Free OCF CAGR (5Y)15.40%
Price vs S&P 500 (52W)-47.22%
P/E Ratio (TTM)7.91x
EPS Growth TTM (YoY)130.56%
Year-to-Date Return-0.83%
5-Day Price Return1.25%
EPS Normalized (Annual)$7.54
ROA (5Y Avg)5.28%
Net Profit Margin (Annual)16.72%
Month-to-Date Return-0.83%
Cash Flow / Share (TTM)$10.73
EBITD / Share (Annual)$7.94
EPS Growth (3Y)-1.31%
Operating Margin (Annual)13.58%
LT Debt / Equity (Annual)0.20x
P/CF (TTM)9.05x
ROI (5Y Avg)7.15%
P/E Excl Extra (TTM)7.91x
LT Debt / Equity (Quarterly)0.20x
EPS Basic Excl Extra (TTM)$11.99
P/TBV (Quarterly)26.35x
Payout Ratio (Annual)85.29%
P/B Ratio (Annual)1.41x
Dividend / Share (TTM)$9.13
Inventory Turnover (TTM)1.50x
Pretax Margin (TTM)16.80%
Book Value / Share (Annual)$69.55
Price vs S&P 500 (13W)-1.32%
Net Margin Growth (5Y)-12.66%
Dividend Yield (TTM)9.67%
Beta0.42x
P/FCF (Annual)9.05x
Revenue / Share (TTM)$68.07
ROE (TTM)17.30%
52-Week Low$74.85
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share) | 1.40x | 69.14% | 72.55% | -8.08% | $47.99 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Sanofi is a diversified pharmaceutical company focused on immunology, vaccines, and rare diseases. Its flagship product, Dupixent, accounts for approximately 30% of total revenue and is jointly commercialized with Regeneron. The company generates 45% of revenue from the United States, 20% from Europe, and 6% from China.